Anti-CD2/JJ
receptor/NN
antibodies/NNS
activate/VBP
the/DT
HIV/NN
long/JJ
terminal/JJ
repeat/NN
in/IN
T/NN
lymphocytes/NNS
./.

The/DT
CD2/NN
T/NN
lymphocyte/NN
glycoprotein/NN
surface/NN
molecule/NN
mediates/VBZ
both/CC
cell/NN
to/TO
cell/NN
adhesion/NN
and/CC
T/NN
cell/NN
activation/NN
,/,
two/CD
processes/NNS
that/WDT
are/VBP
involved/VBN
in/IN
the/DT
spread/NN
of/IN
HIV/NN
infection/NN
./.
=====
Treatment/NN
of/IN
chronically/RB
HIV-infected/JJ
PBMC/NN
with/IN
anti-CD2/JJ
mAb/NN
has/VBZ
been/VBN
shown/VBN
to/TO
induce/VB
the/DT
expression/NN
of/IN
infectious/JJ
virus/NN
from/IN
these/DT
cultures/NNS
./.
=====
In/IN
this/DT
study/NN
we/PRP
investigated/VBD
the/DT
mechanisms/NNS
whereby/WRB
anti-CD2/JJ
antibodies/NNS
stimulate/VBP
viral/JJ
production/NN
./.
=====
We/PRP
demonstrate/VBP
that/IN
treatment/NN
of/IN
transiently/RB
transfected/VBN
T/NN
lymphocytes/NNS
with/IN
anti-CD2/JJ
antibodies/NNS
results/VBZ
in/IN
activation/NN
of/IN
the/DT
HIV/NN
long/JJ
terminal/JJ
repeat/NN
./.
=====
Furthermore/RB
,/,
CAT/NN
assays/NNS
using/VBG
mutated/VBN
HIV/NN
long/JJ
terminal/JJ
repeat-CAT/NN
constructs/NNS
and/CC
gel/NN
shift/NN
assays/NNS
demonstrate/VBP
that/IN
this/DT
activation/NN
is/VBZ
dependent/JJ
on/IN
the/DT
NF-kappa/NN
B/NN
enhancer/NN
./.
=====
These/DT
studies/NNS
suggest/VBP
that/IN
interaction/NN
of/IN
CD2/NN
with/IN
its/PRP$
natural/JJ
ligand/NN
,/,
LFA-3/NN
,/,
may/MD
play/VB
a/DT
role/NN
in/IN
regulation/NN
of/IN
HIV/NN
expression/NN
./.